Skip to content

KZR — Hedge Fund Holders & Catalysts | BiotechEdge

BiotechEdge New: AI Signals

Catalysts Convergence Squeeze Signals Cash Runway Insiders M&A Research

Sign In Start 14-Day Free Trial

Home›Companies›Kezar Life Sciences, Inc. (KZR)

Kezar Life Sciences, Inc.

KZR

Held by 1 specialist biotech fund

1 fund opened new positions.

Share

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

1.5/10

1 fund opened new positions

B

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

OrbiMed Advisors

AI Signal

Signal Note: OrbiMed Exit from Kezar Life Sciences (KZR)

OrbiMed's full exit from KZR is a notable negative signal, particularly given OrbiMed's track record and typical conviction-holding through clinical milestones. Without confirmed near-term catalysts (Phase 2 readouts, partnership announcements) or recent cash position disclosure, the exit suggests either disappointing interim data, competitive positioning concerns, or shifting conviction on KZR's lead program(s).

Unlock full AI analysis — 14-day free trial

Position Trend

May 15, 2025

$940K

1 fund

Aug 14, 2025

$0

0 funds

Nov 14, 2025

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 4 quarters

Catalysts

No catalysts tracked.

Position Details

OrbiMed AdvisorsEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

3 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

APLS1 fund ALMS1 fund CTMX1 fund BSX1 fund ACET1 fund PTCT1 fund ADCT1 fund ARGX1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts: